M, C., G, L., R, F., K, B., R, K., K, N., & A, S. (2008). Nine months to progression using fourth-line liposomally encapsulated paclitaxel against hepatocellular carcinoma. Chemotherapy, 54(4), 309. https://doi.org/10.1159/000151352
Chicago Style (17th ed.) CitationM, Christopeit, Lenz G, Forstpointner R, Bartelheim K, Kühnbach R, Naujoks K, and Schalhorn A. "Nine Months to Progression Using Fourth-line Liposomally Encapsulated Paclitaxel Against Hepatocellular Carcinoma." Chemotherapy 54, no. 4 (2008): 309. https://doi.org/10.1159/000151352.
MLA (9th ed.) CitationM, Christopeit, et al. "Nine Months to Progression Using Fourth-line Liposomally Encapsulated Paclitaxel Against Hepatocellular Carcinoma." Chemotherapy, vol. 54, no. 4, 2008, p. 309, https://doi.org/10.1159/000151352.